Plaque Psoriasis Symptoms in the News

Novartis Progresses with AIN457 – Analyst Blog
Filed under: plaque psoriasis symptoms

Further data presented at the European Academy of Dermatology and Venereology (EADV), by Novartis, for the relief in signs and symptoms of moderate-to-severe plaque psoriasis showed that 12 weeks of treatment with AIN457, improved the quality of life …
Source

STELARA® and moderate to severe plaque psoriasis
Filed under: plaque psoriasis symptoms

Ustekinumab targets interleukin-12 (IL-12) and interleukin-23 (IL-23), naturally occurring proteins that are important in regulating immune responses and are thought to be associated with immune-mediated inflammatory diseases such as plaque psoriasis …
Source

More Plaque Psoriasis Symptoms Information…